CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12 (2014)
- Authors:
- USP affiliated author: TRAINA, FABÍOLA - FMRP
- School: FMRP
- DOI: 10.1371/journal.pone.0091365
- Subjects: MEDULA ÓSSEA (METABOLISMO); CITOMETRIA DE FLUXO; REGULAÇÃO GÊNICA; EXPRESSÃO GÊNICA; LEUCEMIA (GENÉTICA)
- Language: Inglês
- Imprenta:
- Place of publication: San Francisco
- Date published: 2014
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
MELO, Rita de Cássia Carvalho; LONGHINI, Ana Leda; BIGARELLA, Carolina Louzão; et al. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12. PLOS ONE, San Francisco, v. 9, n. 1, p. e85926-1 - e85926-12, 2014. Disponível em: < http://dx.doi.org/10.1371/journal.pone.0091365 > DOI: 10.1371/journal.pone.0091365. -
APA
Melo, R. de C. C., Longhini, A. L., Bigarella, C. L., Baratti, M. O., Traina, F., Favaro, P., et al. (2014). CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12. PLOS ONE, 9( 1), e85926-1 - e85926-12. doi:10.1371/journal.pone.0091365 -
NLM
Melo R de CC, Longhini AL, Bigarella CL, Baratti MO, Traina F, Favaro P, Campos P de M, Saad STO. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12 [Internet]. PLOS ONE. 2014 ; 9( 1): e85926-1 - e85926-12.Available from: http://dx.doi.org/10.1371/journal.pone.0091365 -
Vancouver
Melo R de CC, Longhini AL, Bigarella CL, Baratti MO, Traina F, Favaro P, Campos P de M, Saad STO. CXCR7 is highly expressed in acute lymphoblastic leukemia and potentiates CXCR4 response to CXCL12 [Internet]. PLOS ONE. 2014 ; 9( 1): e85926-1 - e85926-12.Available from: http://dx.doi.org/10.1371/journal.pone.0091365 - SIVA, a target of p53, is downregulated in myelodysplastic syndromes
- ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells
- Elevated hypercoagulability markers in hemoglobin SC disease
- Compound heterozygous RAG2 mutations mimicking hyper IgM syndrome. [Carta]
- Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion
- FMNL1 promotes proliferation and migration of leukemia cells
- MDR-1 and GST polymorphisms are involved in myelodysplasia progression
- Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms. [Carta]
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
Informações sobre o DOI: 10.1371/journal.pone.0091365 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
